September 2025
1. SIMON BD, Harmon SA, Turkbey B
   Reply to "A critical appraisal and methodological inquiry into an automated multimodal deep learning model for predicting biochemical recurrence in prostate cancer".
   Clin Imaging. 2025 Sep 13:110616. doi: 10.1016/j.clinimag.2025.110616.
   

   >> Share

   
   
2. DEFFLER C, Sedeh AE, Leitman E, Ng TSC, et al
   The role of PSMA PET/CT in identifying benign and malignant intracranial lesions in patients with prostate cancer.
   Clin Imaging. 2025 Sep 12:110620. doi: 10.1016/j.clinimag.2025.110620.
   

   >> Share

   
   
3. APHALE P, Dokania S, Shekhar H
   A critical appraisal and methodological inquiry into an automated multimodal deep learning model for predicting biochemical recurrence in prostate cancer.
   Clin Imaging. 2025 Sep 11:110615. doi: 10.1016/j.clinimag.2025.110615.
   

   >> Share

   
   
4. CHIMMULA RR, Green M, Tann M, Koch M, et al
   Comparative analysis of machine learning-derived nomogram and biomarkers in predicting side-specific extraprostatic extension: Preliminary findings.
   Clin Imaging. 2025;125:110556.
   

   >> Share

   
   August 2025
5. SIMON BD, Harmon SA, Merriman KM, Tetreault J, et al
   A multimodal automated deep learning-based model for predicting biochemical recurrence of prostate cancer following prostatectomy from baseline MRI, Presurgical clinical covariates.
   Clin Imaging. 2025;126:110579.
   

   >> Share

   
   July 2025
6. SHAH N, Sedeh AE, Deffler C, Ng TSC, et al
   The role of PSMA PET/CT in distinguishing malignant from benign solitary bone lesions in prostate cancer patients.
   Clin Imaging. 2025;125:110570.
   

   >> Share

   
   June 2025
7. NAKROUR N, Cochran RL, Mercaldo ND, Bradley W, et al
   Impact of artificial intelligence assisted lesion detection on radiologists' interpretation at multiparametric prostate MRI.
   Clin Imaging. 2025;122:110484.
   

   >> Share

   
   April 2025
8. FENNER J, Samim M, Raad RA, Shankar DS, et al
   CT-guided biopsy of 18F-piflufolastat radiotracer avid lesions in osseous metastatic prostate disease: Initial experience, technical factors and biopsy yield.
   Clin Imaging. 2025;120:110437.
   

   >> Share

   
   January 2025
9. ESENGUR OT, Yilmaz EC, Ozyoruk KB, Chen A, et al
   Multimodal approach to optimize biopsy decision-making for PI-RADS 3 lesions on multiparametric MRI.
   Clin Imaging. 2025;117:110363.
   

   >> Share

   
   
10. COCHRAN RL, Milshteyn E, Ghosh S, Nakrour N, et al
    Minimizing prostate diffusion weighted MRI examination time through deep learning reconstruction.
    Clin Imaging. 2025;117:110341.
    

    >> Share

    
    December 2024
11. BLYTHE JA, Ng TSC
    Ethical principles for practice building in the era of targeted radioligand therapy.
    Clin Imaging. 2024;116:110334.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share